• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Elucidation of the novel epigenetic mechanism promoting a subset of hematologic malignancies

Research Project

Project/Area Number 20K07346
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Review Section Basic Section 49010:Pathological biochemistry-related
Research InstitutionKindai University

Principal Investigator

UEDA Takeshi  近畿大学, 医学部, 准教授 (60585149)

Co-Investigator(Kenkyū-buntansha) 金井 昭教  東京大学, 大学院新領域創成科学研究科, 特任准教授 (60549567)
Project Period (FY) 2020-04-01 – 2023-03-31
Project Status Completed (Fiscal Year 2022)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2022: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2021: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2020: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Keywordsエピジェネティクス / 遺伝子発現制御 / 造血器腫瘍
Outline of Research at the Start

ヒストン脱メチル化酵素がその酵素活性とは異なる機序を介して、白血病の病態を促進する可能性を見出した。本研究では、生化学的、細胞生物学的手法によりヒストン脱メチル化酵素による新たなエピゲノム制御機構の分子基盤を明らかにし、白血病治療標的としての可能性を探索する。

Outline of Final Research Achievements

Our prior work has shown that the histone lysine demethylase KDM4B epigenetically promotes acute myeloid leukemia (AML) associated with chromosomal translocation 8;21 [t(8;21)]. In the present study, we demonstrated that each of the proline-rich region, PHD domain, and Tudor domain of KDM4B is required for proliferation of t(8;21) AML cells, besides the demethylase activity of this protein. Among them, the proline-rich region was found to be essential for the interaction with BRG1-chromatin remodeling enzyme.

Academic Significance and Societal Importance of the Research Achievements

本研究課題では特定の染色体異常を伴う急性骨髄性白血病において、ヒストン脱メチル化酵素KDM4Bが、酵素活性非依存的な細胞増殖効果を担うのに必要なアミノ酸領域を明らかにした。治療標的としてKDM4Bの機能を阻害するために有用な知見が得られた。

Report

(4 results)
  • 2022 Annual Research Report   Final Research Report ( PDF )
  • 2021 Research-status Report
  • 2020 Research-status Report
  • Research Products

    (6 results)

All 2023 2022 2021 2020

All Journal Article (6 results) (of which Int'l Joint Research: 2 results,  Peer Reviewed: 6 results,  Open Access: 5 results)

  • [Journal Article] MYC/glutamine dependency is a therapeutic vulnerability in pancreatic cancer with deoxycytidine kinase inactivation-induced gemcitabine resistance2023

    • Author(s)
      Dash Suman, Ueda Takeshi, Komuro Akiyoshi, Amano Hisayuki, Honda Masahiko, Kawazu Masahito, Okada Hitoshi.
    • Journal Title

      Molecular Cancer Research

      Volume: online publication Issue: 5 Pages: 444-457

    • DOI

      10.1158/1541-7786.mcr-22-0554

    • Related Report
      2022 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] CD34+ myeloma cells with self-renewal activities are therapy-resistant and persist as MRD in cell cycle quiescence.2022

    • Author(s)
      Serizawa K; Tanaka H; Ueda T; Fukui A; Kakutani H; Taniguchi T; Inoue H; Kumode T; Taniguchi Y; Rai S; Hirase C; Morita Y; Espinoza JL; Tatsumi Y; Ashida T; Matsumura I
    • Journal Title

      Int J Hematol.

      Volume: 115 Issue: 3 Pages: 336-349

    • DOI

      10.1007/s12185-021-03261-0

    • Related Report
      2021 Research-status Report
    • Peer Reviewed
  • [Journal Article] KDM4B promotes acute myeloid leukemia associated with AML1‐ETO by regulating chromatin accessibility2021

    • Author(s)
      Ueda Takeshi、Kanai Akinori、Komuro Akiyoshi、Amano Hisayuki、Ota Kazushige、Honda Masahiko、Kawazu Masahito、Okada Hitoshi
    • Journal Title

      FASEB BioAdvances

      Volume: 3 Issue: 12 Pages: 1020-1033

    • DOI

      10.1096/fba.2021-00030

    • Related Report
      2021 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] UTX maintains functional integrity of murine hematopoietic system by globally regulating aging-associated genes.2021

    • Author(s)
      Sera Y; Nakata Y; Ueda T; Yamasaki N; Koide S; Kobayashi H; Ikeda KI; Kobatake K; Iwasaki M; Oda H; Wolff L; Kanai A; Nagamachi A; Inaba T; Sotomaru Y; Ichinohe T; Koizumi M; Miyakawa Y; Honda ZI; Iwama A; Suda T; Takubo K; Honda H
    • Journal Title

      Blood.

      Volume: 137 Issue: 7 Pages: 908-922

    • DOI

      10.1182/blood.2019001044

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Ascorbate sensitizes human osteosarcoma cells to the cytostatic effects of cisplatin2020

    • Author(s)
      Oka Naohiro、Komuro Akiyoshi、Amano Hisayuki、Dash Suman、Honda Masahiko、Ota Kazushige、Nishimura Shunji、Ueda Takeshi、Akagi Masao、Okada Hitoshi
    • Journal Title

      Pharmacology Research & Perspectives

      Volume: 8 Issue: 4

    • DOI

      10.1002/prp2.632

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Kdm6a Deficiency Activates Inflammatory Pathways, Promotes M2 Macrophage Polarization, and Causes Bladder Cancer in Cooperation with p53 Dysfunction2020

    • Author(s)
      Kobatake Kohei et al., Honda Zen-ichiro et al. and Honda Hiroaki
    • Journal Title

      Clinical Cancer Research

      Volume: 26 Issue: 8 Pages: 2065-2079

    • DOI

      10.1158/1078-0432.ccr-19-2230

    • Related Report
      2020 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research

URL: 

Published: 2020-04-28   Modified: 2024-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi